Other

Common stock, shares issued (in shares)

STERIS Common stock, shares issued (in shares) decreased by 0.2% to $98.10M in Q4 2025 compared to the prior quarter. Over 2 years (FY 2021 to FY 2025), Common stock, shares issued (in shares) shows a downward trend with a -55.7% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2024
Last reportedQ4 2025

How to read this metric

Increases indicate equity financing or stock-based compensation, while decreases result from share buybacks.

Detailed definition

This represents the total number of shares that the company has distributed to shareholders. It includes both shares cur...

Peer comparison

Used to calculate earnings per share and evaluate dilution trends compared to industry peers.

Metric ID: other_common_stock_shares_issued

Historical Data

5 periods
 Q2 '21Q1 '22Q2 '22Q1 '25Q4 '25
Value$500.00M$500.00M$500.00M$98.30M$98.10M
QoQ Change+0.0%+0.0%-80.3%-0.2%
YoY Change+0.0%
Range$98.10M$500.00M
CAGR-80.4%
Avg YoY Growth+0.0%
Median YoY Growth+0.0%
Current Streak2 quarters decline

Frequently Asked Questions

What is STERIS's common stock, shares issued (in shares)?
STERIS (STE) reported common stock, shares issued (in shares) of $98.10M in Q4 2025.
What is the long-term trend for STERIS's common stock, shares issued (in shares)?
Over 2 years (2021 to 2025), STERIS's common stock, shares issued (in shares) has grown at a -55.7% compound annual growth rate (CAGR), from $500.00M to $98.30M.
What does common stock, shares issued (in shares) mean?
The total number of shares the company has created and distributed to investors.